A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

By Banerjee S.   Rustin G.   Paul J.   Williams C.   Pledge S.   Gabra H.   Skailes G.   Lamont A.   Hindley A.   Goss G.   Gilby E.   Hogg M.   Harper P.   Kipps E.   Lewsley L-A   Hall M.   Vasey P.   Kaye S. B.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 679-687

Oxford University Press

Access to resources Recommend Favorite

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 562-568

Spandidos Publications

Access to resources Recommend Favorite

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite